Loading clinical trials...
Loading clinical trials...
The proposed study is to evaluate the safety and initial efficacy of MRgFUS for patients with treatment-refractory OCD. This study is designed as a prospective, single arm, nonrandomized study. Assess...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sunnybrook Health Sciences Centre
Collaborators
NCT07124780 · Obsessive-Compulsive Disorder (OCD)
NCT05623306 · Obsessive-Compulsive Disorder
NCT06647589 · Obsessive-Compulsive Disorder (OCD)
NCT06585618 · Dystonia, Epilepsy in Children, and more
NCT06804525 · Major Depressive Episode (MDE), Major Depressive Disorder (MDD), and more
Foothill Medical Centre
Calgary, Alberta
Sunnybrook Health Sciences Centre
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions